Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 561

1.

Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex.

Noji M, Kizu R, Takeda Y, Akiyama N, Yoshizaki I, Eriguchi M, Kidani Y.

Biomed Pharmacother. 2005 Jun;59(5):224-9.

PMID:
15919175
3.

Cytotoxicity of platinum(IV) and platinum(II) complexes containing 1R,2R-cyclohexanediamine as a ligand.

Yamashita T, Hirose J, Noji M, Saito R, Tomida H, Kidani Y.

Biol Pharm Bull. 1993 Oct;16(10):1014-8.

PMID:
8287030
4.

Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.

Siddik ZH, al-Baker S, Thai G, Khokhar AR.

Anticancer Drug Des. 1994 Apr;9(2):139-51.

PMID:
8166929
5.
6.

Cytotoxicity, cellular accumulation and DNA binding of oxaliplatin isomers.

Pendyala L, Kidani Y, Perez R, Wilkes J, Bernacki RJ, Creaven PJ.

Cancer Lett. 1995 Nov 6;97(2):177-84.

PMID:
7497460
7.

An orally active antitumor cyclohexanediamine-Pt(IV) complex: trans,cis,cis-bis(n-valerato)(oxalato)(1R,2R-cyclohexane diamine)Pt(IV).

Kizu R, Nakanishi T, Miyazaki M, Tashiro T, Noji M, Matsuzawa A, Eriguchi M, Takeda Y, Akiyama N, Kidani Y.

Anticancer Drugs. 1996 May;7(3):248-56.

PMID:
8791997
8.
9.

Synthesis, characterization, and antitumor activity of new platinum(IV) trans-carboxylate complexes: crystal structure of [Pt(cis-1,4-DACH)trans-(acetate)2Cl2].

Shamsuddin S, Santillan CC, Stark JL, Whitmire KH, Siddik ZH, Khokhar AR.

J Inorg Biochem. 1998 Aug;71(1-2):29-35.

PMID:
9755489
10.
11.
12.

Anticancer activity in murine and human tumor cell lines of bis(platinum) complexes incorporating straight-chain aliphatic diamine linker groups.

Kraker AJ, Hoeschele JD, Elliott WL, Showalter HD, Sercel AD, Farrell NP.

J Med Chem. 1992 Nov 27;35(24):4526-32.

PMID:
1335074
14.
15.

Ascorbato(1,2-diaminocyclohexane):platinum(II) complexes, a new series of water-soluble antitumor drugs.

Hacker MP, Khokhar AR, Brown DB, McCormack JJ, Krakoff IH.

Cancer Res. 1985 Oct;45(10):4748-53.

16.

Antitumor effects of a new lipophilic platinum compound, trans-bis(n-valerato)(1R,2R-cyclohexanediamine)(oxalato)platinum(IV), in mice.

Saegusa Y, Eriguchi M, Kidani Y, Matsuzawa A, Takeda Y.

Anticancer Res. 2001 Jan-Feb;21(1A):245-52.

PMID:
11299742
17.

Synthesis and antitumor activity of 1,2-diaminocyclohexane platinum(IV) complexes.

Khokhar AR, al-Baker S, Siddik ZH.

J Inorg Biochem. 1994 Apr;54(1):39-47.

PMID:
8151310
18.

Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.

Kushev D, Gorneva G, Taxirov S, Spassovska N, Grancharov K.

Biol Chem. 1999 Nov;380(11):1287-94.

PMID:
10614821
19.

Synthesis, antitumor activity, and chemical properties of silaplatin and related platinum (II) and platinum (IV) complexes derived from beta-silyl amines.

Anderson WK, Kasliwal R, Houston DM, Wang YS, Narayanan VL, Haugwitz RD, Plowman J.

J Med Chem. 1995 Sep 15;38(19):3789-97.

PMID:
7562909
20.

Supplemental Content

Support Center